Free Shipping on orders above Rs 449/- Hurry … Limited time Offer

Bharat Biotech to begin paediatric trials of Covaxin from June

The Hyderabad headquartered vaccine maker has recently received approvals from the drug regulator to carry out paediatric trials of the vaccine. Indian vaccine innovator Bharat Biotech International (BBIL), which developed the indigenous Covid-19 vaccine with Indian Council of Medical Research and the National Institute of Virology, will begin clinical trials of the vaccine on paediatrics from June 1